FDG-PET Evaluation of Response to Treatment

被引：1
作者：
Kostakoglu, Lale [1 ]
机构：
[1] Mt Sinai Med Ctr, Dept Radiol, Div Nucl Med, One Gustave Levy Pl,Box 1141, New York, NY 10029 USA
来源：
PET CLINICS | 2008年 / 3卷 / 01期
关键词：
Therapy response; Anticancer therapy; PET; Prediction of response;
D O I：
10.1016/j.cpet.2008.09.001
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
This article discusses evaluating response after and during therapy in various settings and for the types of cancers for which ample evidence demonstrates that PET imaging with flourodeoxyglucose provides a valuable surrogate for response to therapy. It also briefly discusses pitfalls in obtaining an optimal assessment of response and issues that need further attention for this modality to become established as an independent predictor of response to anticancer therapy.
引用
收藏
页码：37 / +
页数：41
相关论文
共 204 条
[1]   An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer [J].
Akhurst, T ;
Downey, RJ ;
Ginsberg, MS ;
Gonen, M ;
Bains, M ;
Korst, R ;
Ginsberg, RJ ;
Rusch, VW ;
Larson, SM .
ANNALS OF THORACIC SURGERY, 2002, 73 (01) :259-264
[2]   A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-D-glucose in murine models of breast cancer [J].
Aliaga, Antonio ;
Rousseau, Jacques A. ;
Cadorette, Jules ;
Croteau, Etienne ;
van Lier, Johan E. ;
Lecomte, Roger ;
Benard, Francois .
MOLECULAR IMAGING AND BIOLOGY, 2007, 9 (03) :144-150
[3]  
Ancona E, 2001, CANCER, V91, P2165, DOI 10.1002/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.0.CO
[4]  
2-H
[5]  
[Anonymous], 2000, COCHRANE DATABASE SY
[6]   Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy [J].
Anscher, MS ;
Chen, LG ;
Rabbani, Z ;
Kang, S ;
Larrier, N ;
Huang, H ;
Samulski, TV ;
Dewhirst, MW ;
Brizel, DM ;
Folz, RJ ;
Vujaskovic, Z .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (01) :255-259
[7]   CHEMOTHERAPY FOR DIFFUSE LARGE-CELL LYMPHOMA - RAPIDLY RESPONDING PATIENTS HAVE MORE DURABLE REMISSIONS [J].
ARMITAGE, JO ;
WEISENBURGER, DD ;
HUTCHINS, M ;
MORAVEC, DF ;
DOWLING, M ;
SORENSEN, S ;
MAILLIARD, J ;
OKERBLOOM, J ;
JOHNSON, PS ;
HOWE, D ;
BASCOM, GK ;
CASEY, J ;
LINDER, J ;
PURTILO, DT .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) :160-164
[8]   Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer [J].
Avril, N ;
Sassen, S ;
Schmalfeldt, B ;
Naehrig, J ;
Rutke, S ;
Weber, WA ;
Werner, M ;
Graeff, H ;
Schwaiger, M ;
Kuhn, W .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7445-7453
[9]  
Avril N, 2001, J NUCL MED, V42, P9
[10]   Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) [J].
Belderbos, Jose ;
Uitterhoeve, Lon ;
van Zandwijk, Nico ;
Belderbos, Huub ;
Rodrigus, Patrick ;
van de Vaart, Paul ;
Belderbos, Huub ;
Rodrigus, Patrick ;
van de Vaart, Paul ;
Price, Allan ;
van Walree, Nico ;
Legrand, Catherine ;
Dussenneh, Sonia ;
Bartelink, Harry ;
Giaccone, Giuseppe ;
Koning, Caro .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (01) :114-121
12345678910